Short-Term Debt to Equity: Mangoceuticals Inc. (MGRX)

This chart of the market valuation for Mangoceuticals, Inc. (MGRX) captures the figure at 0.01. Mangoceuticals, Inc. (MGRX) is developing a digital men's wellness service, implementing smart assistants and pharmacy software. Revenue is generated through the remote sale of medications for alopecia and impotence. The strategy is based on the aggressive digitization of private medical topics and the implementation of algorithms for automated prescription issuance.
Summary analytical data breakdowns for MangoRx (MGRX)

This indicator assesses the company's dependence on short-term liabilities relative to its equity, allowing for the identification of liquidity risks and excessive debt loads. By analyzing the short-term debt-to-equity ratio on the GURU.Markets platform, an investor can gauge the financial stability of Mangoceuticals, Inc. (MGRX), which is critical amid global inflation reducing the demand for paid healthcare services among the US population.